Docking and Molecular Dynamic Simulations Study to Search Curcumin Analogue Compounds as Potential Inhibitor Against SARS-CoV-2: A Computational Approach

*Neni Frimayanti orcid scopus  -  Sekolah Tinggi Ilmu Farmasi Riau, Indonesia
Adel Zamri orcid scopus  -  Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Indonesia
Yum Eryanti orcid scopus  -  Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Indonesia
Noval Herfindo  -  Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Indonesia
Veza Azteria  -  Study Program of Public Health, Faculty of Health Science, Esa Unggul University, Indonesia
Received: 17 Nov 2020; Revised: 24 Mar 2021; Accepted: 29 Mar 2021; Published: 31 Mar 2021.
Open Access Copyright 2021 Jurnal Kimia Sains dan Aplikasi
License URL: http://creativecommons.org/licenses/by-sa/4.0

Citation Format:
Cover Image
Abstract
Coronavirus is a pandemic in the world. It requires researchers and scientists to work hard to find a vaccine or drug to inhibit the development of the coronavirus. Many drugs have been used, such as remdesivir, lopinavir, and chloroquine. However, how effective is the use of these drugs for inhibiting the coronavirus’s growth? There is no research has been done. Curcumin is now known as one of the compounds that have some biological activities, and it is also can potentially be used as a CoV-2 inhibitor. The computational study, i.e., molecular docking and molecular dynamic, can help researchers to predict which compounds have the potential as an inhibitor against the CoV-2 coronavirus. In this study, lopinavir was used as a positive control. Lopinavir and 45 curcumin analog compounds were docked against the main protease protein with 6LU7 PDB ID. Based on the docking results, it was discovered that compound 1, compound 2, and compound 4 have the same binding orientation as lopinavir. Molecular dynamic simulation with the lowest binding free energy conformation was used to check these compounds’ stability. Only compound 4 was maintained to observe hydrogen bonding with Lys5 and Lys137 with a distance of 2.9 Å. The distance of hydrogen bonds and binding free energy over simulation time is essential to elucidate the potential compound’s affinity. For then, compound 4 can be used as a potential inhibitor against the CoV-2 coronavirus.
Keywords: coronavirus; docking; molecular dynamic; curcumin; lopinavir
Funding: Sekolah Tinggi Ilmu Farmasi Riau

Article Metrics:

  1. Wei Ji, Wei Wang, Xiaofang Zhao, Junjie Zai, Xingguang Li, Cross-species transmission of the newly identified coronavirus 2019-nCoV, Journal of Medical Virology, 92, 4, (2020), 433-440 https://doi.org/10.1002/jmv.25682
  2. Jun He, Lijun Hu, Xiaojun Huang, Chenran Wang, Zhimin Zhang, Ying Wang, Dongmei Zhang, Wencai Ye, Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors, International Journal of Antimicrobial Agents, 56, 2, (2020), 106055 https://doi.org/10.1016/j.ijantimicag.2020.106055
  3. World Health Organization, Coronavirus disease (COVID-19) pandemic Dashboard, WHO, 2020
  4. Christian A. Devaux, Jean-Marc Rolain, Philippe Colson, Didier Raoult, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, International Journal of Antimicrobial Agents, 55, 5, (2020), 105938 https://doi.org/10.1016/j.ijantimicag.2020.105938
  5. Thanigaimalai Pillaiyar, Sangeetha Meenakshisundaram, Manoj Manickam, Recent discovery and development of inhibitors targeting coronaviruses, Drug Discovery Today, 25, 4, (2020), 668-688 https://doi.org/10.1016/j.drudis.2020.01.015
  6. Atala B. Jena, Namrata Kanungo, Vinayak Nayak, G. B. N. Chainy, Jagneshwar Dandapat, Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies, Scientific Reports, 11, 1, (2021), 2043 https://doi.org/10.1038/s41598-021-81462-7
  7. Yum Eryanti, Adel Zamri, Neni Frimayanti, Hilwan Yuda Teruna, Unang Supratmman, Tati Herlina, Yoshihito Shiono, Synthesis, structure-activity relationship, docking and molecular dynamic simulation of curcumin analogues against HL-60 for anticancer agents (leukemia), Oriental Journal of Chemistry, 33, 5, (2017), 2164-2172 https://doi.org/10.13005/ojc/330503
  8. Bodee Nutho, Panupong Mahalapbutr, Kowit Hengphasatporn, Nawanwat Chainuwong Pattaranggoon, Nattapon Simanon, Yasuteru Shigeta, Supot Hannongbua, Thanyada Rungrotmongkol, Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms, Biochemistry, 59, 18, (2020), 1769-1779 https://doi.org/10.1021/acs.biochem.0c00160
  9. Jasril Jasril, New Fluorinated Chalcone and Pyrazolines Analogues: Synthesis, Docking and Molecular Dynamic Studies as Anticancer Agents, Thai Journal of Pharmaceutical Sciences (TJPS), 41, 3, (2017), 93-98
  10. Neni Frimayanti, Marzieh Yaeghoobi, Hamid Namavar, Ihsan Ikhtiarudin, Meysam Afzali, In silico studies and biological evaluation of chalcone-based 1, 5-benzothiazepines as new potential H1N1 neuraminidase inhibitors, Journal of Applied Pharmaceutical Science, 10, 10, (2020), 86-94 https://doi.org/10.7324/JAPS.2020.1010010
  11. Akihiro Okamoto, Yoshihide Tokunou, Junki Saito, Cation-limited kinetic model for microbial extracellular electron transport via an outer membrane cytochrome C complex, Biophysics and physicobiology, 13, (2016), 71-76 https://doi.org/10.2142/biophysico.13.0_71
  12. Mohd Shahbaaz, Mohd Amir, Safikur Rahman, Gulam Mustafa Hasan, Ravins Dohare, Krishna Bisetty, Faizan Ahmad, Jihoe Kim, Md Imtaiyaz Hassan, Structural insights into Rab21 GTPase activation mechanism by molecular dynamics simulations, Molecular Simulation, 44, 3, (2018), 179-189 https://doi.org/10.1080/08927022.2017.1357813

Last update: 2021-05-15 22:13:50

No citation recorded.

Last update: 2021-05-15 22:13:50

No citation recorded.